Immunoglobulin A nephropathy (IgAN) is a form of primary glumerulonephritis that causes kidney disease in young adults characterized by prominent polymeric IgA deposition within the glomerular mesangium, leading to mesangial proliferation and sclerosis. IgAN is considered an autoimmune dise-ase partly caused by an abnormal 0-glycosylation of the IgAl molecule. Because of the deficiency of 131,3 galactose in the hinge-region of IgAi molecule it has an increased tendency of self-aggregation and/or the increased binding capacity for circulating glycoproteins. The knowledge about IGAN indicates that at least four events contribute in the development of IgA nephropathy i.E. aberrant glycosylation of IgAi, synthesis of anti-galactose - deficient IgAi antibodies, binding of the galactose - deficient IgAi by the anti-glycan/glycopeptides antibodies to form immune complexes (ICs), and accumulation of these complexes in the glomerular mesangium to initiate renal injury. IgAN is considered to be a complex disorder and like other complex diseases it also does not obey single gene Mendelian inheritance pat-tern. In addition to genetic factors, environmental stimuli and various inflammatory mediators are also considered to play role in IgAN pathogenesis. Variable disease prevalence in European, Asian and Afri-can cohorts indicate the role of susceptibility genes of variable frequencies in these populations. Familial IgAN has also been reported all over the world. After family studies three genetic loci IGANi, IGAN2 and IGAN3 on chromosome 6q22-23, 4q26-31 and 17q12-22 respectively have been reported to be associated with IgAN. Based upon their functional involvement, several genes like core-i-B, 3-G alac-tosyltransferase (CiGALTi) and its specific molecular chaperone bi, 3-GT (CiGALTiCi) Ga1NAc a2, 6- sialyltransferase (ST6GALNAC2) transferrin receptor (TFRC) immunoglobulin A, Fca receptor (CD89) and toll - like receptor 4 (TLR4) become promising candidate genes for IgAN. SNP analysis from the candidate genes suggested that polymorphisms in CiGALTi and TLR4 genes might influence the risk to develop IgAN. Further genetic association studies revealed more candidate genes i.E. HLA (human leu-kocyte antigen), renin-angiotensin system-related genes (RAS), complement factor immunoglobulins and cytokines, T-cell receptor alpha or beta chain genes are related to the predisposition and progress-ion of the IgAN disease.